| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.005 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.005 |